These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 12228219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients.
    Garufi C, Vanni B, Aschelter AM, Zappalà AR, Bria E, Nisticò C, Sperduti I, Cognetti F, Terzoli E.
    Eur J Cancer; 2006 Mar; 42(5):608-16. PubMed ID: 16246545
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Mar; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
    Kang EJ, Choi YJ, Kim JS, Kim ST, Park KH, Choi IK, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH.
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778
    [Abstract] [Full Text] [Related]

  • 6. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V.
    Lancet; 1997 Nov 01; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z, Eng C.
    Clin Adv Hematol Oncol; 2007 Jan 01; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract] [Full Text] [Related]

  • 9. First-line treatment options for patients with metastatic colorectal cancer.
    Schilsky RL.
    Nat Clin Pract Oncol; 2004 Dec 01; 1(2):70-1. PubMed ID: 16264820
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma.
    Petrelli NJ, Rustum YM, Bruckner H, Stablein D.
    Adv Exp Med Biol; 1988 Dec 01; 244():143-55. PubMed ID: 3073651
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM, Banerjee TK, Davis HL, Zaentz SD, Schiferl EA, Ousley JL, Pogodzinski AE, Trump DL.
    Wis Med J; 1988 May 01; 87(5):20-3. PubMed ID: 3291405
    [No Abstract] [Full Text] [Related]

  • 18. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
    Xu N, Fang WJ, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Shen P.
    Cancer Invest; 2007 May 01; 25(7):599-605. PubMed ID: 17882631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.